What a fantastic seminar by Florian Bassermann from TU München on “Aberrant ubiquitin network in Multiple Myeloma” organized by the #SFB1530 Michael Hallek , followed by a really stimulating discussion. #ubiquitin #myeloma #degron #k48

Could not agree more. Looking forward to the conference and to the stimulating discussions #ubiquitin Fusion Conferences

My Saturday read: an absolute must!

This week we had the amazing pleasure to have Andreas Linkermann presenting some of his fantastic work. An absolute stimulating visit with an expert, a collegue and friend!

Fantastic work and an honour to collaborate with such an amazing group of scientists. 💯

Celebration time for the LiccardiLab . Once again congratulations Konstantinos k. for your paper. #goodtimes Debora Bonasera Hassan Rakhsh-Khorshid Julia Saggau Anne Berghaus Мижиддорж

What a fantastic couple days with James Murphy James Murphy. It was great to have you in Köln. Amazing discussions, fantastic science and of course a pleasure to catch up. Till next time .

✨What a group!✨Some fantastic research shared so far and there’s still much more to come. We’re looking forward to some down time in the Portuguese sunshine to rest and reset for this afternoons session #Ubiq24

Busy at work at the #ubiq24 Fusion conference with ⁦Ron Jachimowicz⁩ ⁦Gianmaria Liccardi⁩ ⁦Nieves Peltzer⁩ ⁦João Mello-Vieira⁩ ⁦Jonathan Pruneda⁩ ⁦Vishva Dixit⁩ #ubiquitin

What a talk on fantastic work spearheaded by our own Julia Saggau discussing the regulation of LUBAC by DUBs. Walczak Lab LiccardiLab Happening at Fusion Conferences #ubiqui24

A fantastic evening of dancing and singing in the company of some of the greatest minds of the field. #ubiqui24 Fusion Conferences

Our own Debora Bonasera delivered a fantastic talk in the final session of the Fusion Conferences on ubiqutin. Great discussion and feedback ! More soon😉

Another amazing piece of work on LUBAC. Congratulations to Walczak Lab Nieves Peltzer , Diego De Miguel and Chen and all other collaborators !

Great review on Cancer immune evasion!

RAS-mutant leukaemia stem cells drive clinical resistance to venetoclax

Promising new treatment approach for severe COVID-19! Clinical trial with Fas ligand blocker shows faster recovery & reduced mortality. Approach targets immune overreaction, potentially effective against future viruses too. #COVID19 #Science #PublicHealth t.ly/6kalU

Now also available on bsky Gianmaria-liccardi.bsky.social 🦋 bsky.app/profile/gianma…

A truly inspiring and insightful lecture by Prof. Michael Hallek today on the future of oncological therapies. Groundbreaking advances meet pressing questions of affordability. Thank you for a thought-provoking evening! #Oncology #MedicalInnovation